中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
29期
71-72
,共2页
艾滋病%HAART%CD4+T淋巴细胞计数%病毒载量
艾滋病%HAART%CD4+T淋巴細胞計數%病毒載量
애자병%HAART%CD4+T림파세포계수%병독재량
HIV/AIDS%HAART%CD4+T lymphocytes count%Viral load
目的:评价HIV/AIDS高效抗逆转录病毒治疗(HAART)方案的疗效。方法:对治疗满1年的147例艾滋病病毒感染者的CD4+T淋巴细胞及病毒载量的检测结果进行统计分析。结果:HAART的患者CD4+T淋巴细胞在6个月后有了明显的升高,6个月、12个月CD4+T淋巴细胞计数分别为(336.95±165.55)个/μl、(344.81±169.28)个/μl;HAART的患者病毒载量12个月后,有78.23%的患者<50 copies/ml。结论:HAART疗效明显,但在抗病毒治疗过程中必须要注意对病毒载量的监测,对于病毒载量>1000 copies/ml的患者要进行耐药检测,及时调整用药方案。
目的:評價HIV/AIDS高效抗逆轉錄病毒治療(HAART)方案的療效。方法:對治療滿1年的147例艾滋病病毒感染者的CD4+T淋巴細胞及病毒載量的檢測結果進行統計分析。結果:HAART的患者CD4+T淋巴細胞在6箇月後有瞭明顯的升高,6箇月、12箇月CD4+T淋巴細胞計數分彆為(336.95±165.55)箇/μl、(344.81±169.28)箇/μl;HAART的患者病毒載量12箇月後,有78.23%的患者<50 copies/ml。結論:HAART療效明顯,但在抗病毒治療過程中必鬚要註意對病毒載量的鑑測,對于病毒載量>1000 copies/ml的患者要進行耐藥檢測,及時調整用藥方案。
목적:평개HIV/AIDS고효항역전록병독치료(HAART)방안적료효。방법:대치료만1년적147례애자병병독감염자적CD4+T림파세포급병독재량적검측결과진행통계분석。결과:HAART적환자CD4+T림파세포재6개월후유료명현적승고,6개월、12개월CD4+T림파세포계수분별위(336.95±165.55)개/μl、(344.81±169.28)개/μl;HAART적환자병독재량12개월후,유78.23%적환자<50 copies/ml。결론:HAART료효명현,단재항병독치료과정중필수요주의대병독재량적감측,대우병독재량>1000 copies/ml적환자요진행내약검측,급시조정용약방안。
Objective:To evaluate the effect of highly active anti-retroviral therapy of HIV/AIDS patient. Method:One hundred and forty-seven cases of HIV virus infection patients treated over a year were retrospective investigated. Result:The CD4+T lymphocyte in 147 patients received highly active antiretroviral therapy was obviously increased after 6 months. At 6 months and 12 months after treatment the CD4+T lymphocyte count were (336.95±165.55)/μl and (344.81±169.28)/μl,respectively. The proportion of patients with viral load<50 copies/ml was 78.23%when received HAART for a year. Conclusion:The curative effect of HAART is obvious,but viral load monitor must be put into effect in the course of antiviral treatment. When the viral load of patients is more than 1000 copies/ml,patients’ viral load need to be tested constantly and medication program need to adjust in time.